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Aim: The aim of this study was to determine whether cannabi- 
noids have direct effects on chondrocyte nitric oxide production 
and cartilage proteoglycan breakdown which may be chon- 
droprotective. 
Methods: The effects of cannabinoids anandamide and R-(+)-win 
55, 212-2 (win-55), both agonists of cannabinoid receptors CB1 
and CB2, were studied on chondrocyte nitric oxide (NO) produc- 
tion and cartilage proteoglycan breakdown. Bovine articular 
chondrocytes were used to study NO production. These were 
prepared by sequential enzymic digestion and plated directly into 
24-well plates at high density (2 x 105/cm2). After 5 days they 
were incubated with win-55 (0.01 -- 10 ;LM) or anandamide (1- 
100 XM) in the presence or absence of interleukin lc~ (IL-lc~) 
(100U/ml) for 48h. NO production was determined in culture 
media using the Greiss reaction. Cartilage proteoglycan break- 
down was determined using cultured bovine nasal cartilage 
explants, unstimulated or stimulated to resorb with IL-la 
(500U/ml) in the presence or absence of win-55 (10-100 ~.M). 
Results: Both anandamide and win-55 inhibited IL-1 stimulated 
NO production, win-55 being the more potent inhibitor producing 
inhibition at 1-10 mM compared with 50-100 mM for anan- 
damide. Preliminary studies have also shown inhibition of IL-1 
stimulated cartilage proteoglycan breakdown by win-55 at 10 and 
100 ~.M. 
Conclusions: Our studies indicate that cannabinoids may be 
chondroprotective, possibly in part by inhibition of NO produc- 
tion. Other workers have previously shown anti-arthritic effects of 
cannabinoids in animal models of arthritis which our observations 
suggest could be mediated by effects on chondrocyte metabo- 
lism. 
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Interest in new therapies for arthritis is timely and the research for 
chondroprotective agents is the subject of many studies. 
Amongst the most notable is glucosamine (GIcN) (i.e. glu- 
cosamine-SO 4, glucosaniine-HCI) with the variety of studies 
demonstrating efficacy at modulating chondrocyte function and 
joint pathology. It has remained ambiguous as to whether ingest- 
ed GLcN makes its way to the joint. We built on our recent in vitro 
experiments (A&R 44:1089-1095), showing that cartilage xplants 
13 GIcN result in the detechon of cultured in medium containing C- " ' 
13C in galactosarnine moieties of chondroitin sulfate. We 
designed a study to trace the fate of orally dosed GIcN in the dog 
using 13C-GIcN and the sensitive techniques of inductively cou- 
pled plasma mass spectroscopy (ICP-MS) and NMR spec- 
troscopy. Two dogs were treated with 13C-glucosamine-HCL by 
oral dosing (combined with food). Dog 1 was given 500 
mg/dog/day (-50 mg/kg/day) for 2 weeks and dog 2, 250 
mg/dog/day for 3 weeks. Cartilage was harvested from the 
femoral condyles, along with liver, spleen, heart, kidney, skin, 
skeletal muscle, lung, and costal cartilage (treated and control 
S41 
dogs). Tissues were prepared for ICP-MS (Perkin;Eliner E~n 
6000) by digestion with nitric acid and analyzed for J~C and ~°C 
in triplicate (identical to 0.01%). The articular cartilage from dog 1 
(high dose) showed an increase of 2.6% of 13 C compared with 
control and dog 2 (low dose) an increase of 1.6%. These data 
were confirmed by NMR spectroscopy where all five peaks in the 
anomeric region of 13 C NMR spectra (G1 cUA and GalNac peaks 
from chondroitin sulfate(CS)-4 and CS-6 and keratan sulfate, 
respectively) were all elevated in both treated ogs compared to 
controls. The 12C/13 C ratios of other tissues were analyzed to 
determine the distribution of 13C_G1cN. As expected, the liver 
had the highest 13 C percentage of the other tissues but all were 
less than articular cartilage. Considering the natural stability of 
12C/13C ratios, rate of biosynthesis, and the single 13C per 
GlcN, the increases are well within the expected range if 13C- 
G1 cN was incorporated into proteoglycans. These results for the 
first time provide convincing evidence that oral GtcN is bioavail- 
able to chondrocytes in joint cartilage thereby potentially having 
an affect on the available GIcN for proteoglycan biosynthesis. 
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Introduction: Osteoarthritis (OA) is associated with matrix degra- 
dation, nitric oxide (NO) production and chondrocyte death by 
apoptosis. Increasing lines of evidence suggest a key role for 
mitochondria in apoptosis and ageing. 
Aims: To analyze the biochemical parameters to define the 
Activity of Mitochondrial Respiratory Chain Complexes (AMRCC) 
in human chondrocytes from normal and OA cartilage. To study 
the aged-related changes on AMRCC and to examine the effect 
of NO on AMRCC. 
Materials and Methods: Nineteen normal and 53 OA cartilages 
were used (ages: 40-90 years). The activities of NADH CoQ oxi- 
doreductase (Complex I), succinate dehydrogenase (Complex II), 
Docylubiquinol: ferricytochrome c oxidoreductase (Complex III), 
cytochrome coxidase (Complex IV) and citrate synthase were 
measured using Beckman DU-650 spectrophotometer to monitor 
the reduction of ferricyanide (Complex I), 2,6-dichlorophenolin- 
dophenol (Complex ]1), cytochrome c (Complex III), oxidation of 
cytochrome c (Complex IV) and appearance of free coenzyme A 
(citrate synthase). Variation on mitochondrial membrane potential 
was measured by 5,5', 6, 6'-tetracholoro-l,l ', 3, 3'- 
tetraethylbenzimidazole carbocyanide iodide (JC- I) using flow 
cytometry. Statistic analysis was carried out using U-Mann 
Whitney and Pearson's tests. 
Results: tn base on citrate synthase activity, OA chondrocytes 
have more mitochondrias than normal chondrocytes (13.6%). 
However, the AMRCC is altered on OA chondrocytes. The activi- 
ty of complex II is decreased by 3 7.6% in OA cells with regard to 
normal cells. These differences between OA and normal cells are 
independent of age. A comparative analysis by classes of age 
from 40 to 70 and from 70 to 90 between normal and OA chon- 
drocytes shows a reduction in activity of complex II (about 37%). 
The analysis of correlation between ageing and mitochondrial 
activity on normal and OA chondrocytes did not show any signif- 
icant association. The administration of NO as Sodium 
NitroPrusside (SNP), causes a reduction in activity of complex 11 
(32.8%) and IV (25.5%) on normal chondrocytes. Furthermore, 
NO decreases the mitochondriat membrane potential by a 24% 
quantified by flow cytometry. 
